Myocardial blood flow quantification by Rb-82 cardiac PET/CT: A detailed reproducibility study between two semi-automatic analysis programs. by Dunet, V. et al.
ORIGINAL ARTICLE
Myocardial blood flow quantification by Rb-82
cardiac PET/CT: A detailed reproducibility study
between two semi-automatic analysis programs
Vincent Dunet, MD, BSc,a Ran Klein, PhD,b Gilles Allenbach, MD,a
Jennifer Renaud, MSc,b Robert A. deKemp, PhD,b and John O. Prior, PhD, MDa
a Department of Nuclear Medicine and Molecular Imaging, Lausanne University Hospital,
Lausanne, Switzerland
b University of Ottawa Heart Institute, Cardiac PET Centre, Ottawa, Canada
Received Nov 15, 2014; accepted Apr 7, 2015
doi:10.1007/s12350-015-0151-2
Background. Several analysis software packages for myocardial blood flow (MBF) quan-
tification from cardiac PET studies exist, but they have not been compared using concordance
analysis, which can characterize precision and bias separately. Reproducible measurements are
needed for quantification to fully develop its clinical potential.
Methods. Fifty-one patients underwent dynamic Rb-82 PET at rest and during adenosine
stress. Data were processed with PMOD and FlowQuant (Lortie model). MBF and myocardial
flow reserve (MFR) polar maps were quantified and analyzed using a 17-segment model.
Comparisons used Pearson’s correlation q (measuring precision), Bland and Altman limit-of-
agreement and Lin’s concordance correlation qc 5 qCb (Cb measuring systematic bias).
Results. Lin’s concordance and Pearson’s correlation values were very similar, suggesting
no systematic bias between software packages with an excellent precision q for MBF (q 5 0.97,
qc 5 0.96, Cb 5 0.99) and good precision for MFR (q 5 0.83, qc 5 0.76, Cb 5 0.92). On a per-
segment basis, no mean bias was observed on Bland-Altman plots, although PMOD provided
slightly higher values than FlowQuant at higher MBF and MFR values (P < .0001).
Conclusions. Concordance between software packages was excellent for MBF and MFR,
despite higher values by PMOD at higher MBF values. Both software packages can be used
interchangeably for quantification in daily practice of Rb-82 cardiac PET. (J Nucl Cardiol 2015)
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INTRODUCTION
Myocardial perfusion imaging is an important step
for diagnosis and management of coronary artery disease.
Cardiac positron emission tomography (PET) with var-
ious positron-emitting tracers such as 13N-Ammonia, 15O-
water, or the cationic potassium analog 82Rb, is a well-
known modality to study myocardial perfusion at rest and
in response to physiological or pharmacological stress.1,2
Moreover, it allows regional myocardial blood flow
(MBF) quantification and assessment of myocardial flow
reserve (MFR), extending the diagnostic potential of
standard myocardial perfusion imaging, especially for
patientswith 3-vessel disease, bundle branch block.3 Flow
measurements are useful for the assessment of the extent
and severity of coronary epicardial vascular disease, as
well as diffuse abnormal microcirculatory function with-
out coronary stenosis.4 Furthermore, it leads to a better
statement of the coronary risk, screening of predictive
factors of cardiovascular events, and monitoring of the
effectiveness of therapeutic strategies for cardiovascular
risk reduction.5-7
MBF can be estimated by automatic or semi-
automatic software packages, following a kinetic mod-
eling approach, using time-activity curves derived from
dynamic PET acquisitions. The choice of the compart-
mental modeling method depends on the biodistribution
and kinetics of the perfusion radiotracer. With the
increased availability of PET scanners mainly driven by
oncological applications, there is a clear interest in the
use of cyclotron-free, generator-produced radioisotope
82Rb.8 Several tracer kinetic models have been validated
for MBF quantification by 82Rb cardiac PET.9-13 In
particular, the 1-tissue-compartment model (also called
2-compartment model with a vascular and a cellular
compartment) described by Lortie et al. allows MBF
estimation with good test-retest repeatability and repro-
ducibility among centers.13-17 A recent review of 10
different software packages for MBF quantification has
been performed by Saraste et al. and shows that MBF
quantification is advancing to become a clinical reality.18
However, Bateman and Case questioned in a recent
editorial as to whether MBF values were sufficiently
robust for altering clinical management.19 Thus, before
answering this question, there is a need to better under-
stand the inherent differences between software packages.
To the best of our knowledge, several studies
compared the effects of different acquisition protocols,
modeling approaches, and software packages on MBF
quantitative analysis,20-24 but none has compared the
effect on quantifying 82Rb myocardial blood flow with
different software packages and its clinical conse-
quences using contemporary statistical methods, such
as Lin’s analysis of concordance.25,26 This method is
Figure 1. Illustration of the Lin’s concordance with separate
assessment of (A) of how far the fitted relationship between x
and y data deviates from the 45 concordance line through the
origin (systematic bias) and (B) how far each data point
deviates from the fitted line (precision = Pearson’s q). The
identity line (dashed, y = x) and the reduced major axis linear
regression (solid) are shown. Both graphics illustrate identical
concordance qc = 0.70. However, (A) shows an excellent
precision (q = 0.97) with low scatter but a systematic bias
(Cb = 0.72), while (B) shows no bias (excellent Cb = 0.97)
and a lower precision with more scattered measurements (fair
q = 0.72).
See related editorial, doi:10.1007/s12350-
015-0175-7.
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analogous to the kappa coefficient, but for continuous
scale data. It was developed more than 20 years ago, but
it is not so frequently used outside statistical journals. It
avoids many drawbacks of conventional comparison
methods used traditionally (mean difference, Pearson’s
correlation, linear regression, or intra-class correlation).
It has rarely been used in imaging and only once in
relation to comparing PET-measured MBF.13 Thus, we
aimed to understand the differences in MBF quantifica-
tion between two available processing software
packages for 82Rb cardiac PET studies using Lin’s
analysis of concordance. This statistic of agreement
provides separate measurements of precision (agreement
of individual measurements or the degree of scatter) and
systematic bias (agreement of the mean measurements)
of MBF quantification (Figure 1), whose understanding
is needed before adopting widespread clinical use.
MATERIALS AND METHODS
Population
Fifty-one patients (20 women, 31 men) with known or
suspected coronary artery disease undergoing myocardial
blood flow imaging at the Lausanne University Hospital
participated in the study. The population clinical characteris-
tics are summarized in Table 1. Each patient underwent
dynamic 82Rb cardiac PET acquisition at rest and during
pharmacological stress by infusion of adenosine (140lg/kg/
min over 6 minutes) with qualitative perfusion analysis, and
MBF and MFR assessment. The local Ethics Committee
approved the study protocol and all subjects gave written
informed consent prior to enrolment.
Patient Preparation
Patients were instructed to refrain from caffeine-contain-
ing beverages for at least 12 hours and from food at least
6 hours prior to the test. An EKG at rest was recorded to
ensure the absence of an II- or III-degree atrio-ventricular
block that is a contraindication for adenosine. Afterwards, a
venous catheter was placed on one forearm, and an armband
for blood pressure monitoring was placed on the other arm.
Every patient was imaged in supine position with arms above
the head, wedged with cushions to prevent sliding. Blood
pressure was controlled at rest before any infusion of
adenosine to ensure the absence of hypotension.
Acquisition Protocol
Data acquisitions were performed with a Discovery LS
PET/CT (GE HealthCare, Waukesha, WI) in 2-D mode using a
multi-frame acquisition protocol over 6 minutes (12 9 8 sec-
onds, 5 9 12 seconds, 1 9 30 seconds, 1 9 60 seconds,
1 9 120 seconds) started immediately after a 30-seconds
square-wave infusion of 1450 MBq of [82Rb] rubidium chlo-
ride at rest.27 The same acquisition protocol was used for stress
imaging starting 2 minutes after the beginning of adenosine
infusion. Two low-dose CT scans (120 keV, 10 mAs) were
acquired for attenuation correction, one just before the rest
study and one immediately after the stress study. CT images
were manually reviewed for accurate coregistration with the
PET images. Dynamic transverse images were reconstructed
using OSEM with a Hann loop filter of 2.34 mm full-width at
half maximum (FWHM) and a Hann post-filter of 3.27 mm
FWHM. The arterial blood pressure and heart rate, as well as
the 12-lead EKG were continuously monitored. The total time
in the PET/CT scanner was about 20 minutes and the effective
dose due to 82Rb was about 2 mSv for both rest and stress
acquisitions, including the CT dose.28
Image Processing
Datasets were systematically processed with two software
packages for quantitative analysis of MBF: (i) the commercial
PMOD 3.0 (PMOD Technologies Ltd. Zurich, Switzerland)
and (ii) the academic FlowQuant 2.1.3.14,17 Both programs use
the same, previously described 1-tissue-compartment model,
corrected for 82Rb flow-dependent extraction, myocardial
partial-volume recovery, and blood spillover.14 Note that both
software packages correct for spillover of the left ventricle
(LV) blood, while PMOD also corrects for the right ventricle
blood spillover in septal segments.
The myocardial uptake Cm(t) was determined by averag-
ing the late image frames and performing sampling as
described below for each software package. PMOD used the
Table 1. Population clinical characteristics
(n = 51)
Mean ± SD
or # (%)
Age (years) 63 ± 12
Gender 31 (61%) M;
20 (39%) W
Weight (kg) 81 ± 17
Body mass index (kg/m2) 28.2 ± 5.4
Obesity: body mass
index[30 kg/m2
35 (69%)
Diabetes history 16 (31%)
Arterial hypertension: C140/
90 mmHg
30 (59%)
Dyslipidemia: LDL C 4.1 mmol/L
(160 mg/dL) or HDL B 0.8 mmol/L
(30 mg/dL)
23 (45%)
Smoking history 16 (31%)
Family history of heart disease 8 (16%)
Known coronary artery stenosis 7 (14%)
Previous coronary artery bypass
surgery
5 (10%)
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early phase to determine the LV blood pool region, while
FlowQuant used a region extending from mid cavity to atrium
at maximum distance from the mid-myocardium region.
CLV(t), assumed to be the uptake function of the model, was
acquired by sampling in the respective blood pool regions. The
model parameters (K1, k2, FLV) were estimated using a
weighted least-squares method to satisfy Equations (1) and (2):
Cm tð Þ ¼ K1  ek2t  CLV tð Þ; ð1Þ
CPET tð Þ ¼ FLV  CLV tð Þ þ 1FLVð Þ  Cm tð Þ; ð2Þ
where FLV is a real number between 0 and 1 and (1 - FLV) is
a regional estimation of the myocardial partial-volume
recovery coefficient. The K1 uptake parameter was related to
MBF using a Renkin-Crone function:
K1 ¼ MBF  1a  eb=MBF
 
: ð3Þ
For both software packages, the a and b constant values
were identical, respectively, a = 0.77 and b = 0.63 mL/min/
g.14
PMOD processing. After loading DICOM files,
PMOD automatically generated blood pool (BP) and myocar-
dial images from dynamic uptake series by averaging
respective frames, from 10 to 70 seconds for BP and from 2
to 6 minutes for myocardium, then smoothing with a 3-D
Gaussian filter of 6-mm FWHM. Then, standard reorientation
of the heart was performed; PMOD determined volumes-of-
interest (VOI) in the left ventricle, right ventricle, and in the
centerline of myocardium were applied before sampling and
the corresponding time-activity-curves (TACs) were generat-
ed. Finally, uptake parameters were determined by fitting the
tracer kinetic model to the TACs (Equation 1, 2), leading to
MBF calculation (Equation 3), except that for septal segments
Equation 2 was replaced by
CPET tð Þ ¼ FLV  CLV tð Þ þ FRV  CRV tð Þ
þ 1FLVFRVð Þ  Cm tð Þ; ð4Þ
where FLV and FRV are real numbers between 0 and 1 and
(1 - FLV - FRV) is a regional estimation of the myocardial
partial-volume recovery coefficient. The resulting parameters
from each segment were finally displayed in a polar plot cor-
responding to the 17-segment AHA scheme, and used for
generating MBF reports.
FlowQuant processing. After loading adequate
DICOM files, FlowQuant proceeded to perform standard
reorientation of the heart using a myocardium uptake image
generated by summing the last 5 uptake frames (2.2-6 minutes)
and applying a 3-D Gaussian filter (complementing the image
resolution to 12-mm FWHM). After reorientation, the software
detected the mid-myocardium in the image volume to generate
myocardial time-activity-curves. The BP median TAC was
created from three samples located in the LV cavity, the LV
base, and the left atrium. The 1-tissue-compartment model was
then fitted to the measured TACs and uptake rates were
determined, and subsequently converted to MBF estimates.
FlowQuant finally generated a series of polar maps for the
activity uptake, MBF, K1, blood spillover (FLV), as well as the
reduced v2 and R-squared values of the fit. Results of MBF at
rest, at stress and MFR were compared for global LV and
segmental territories using the 17-segment AHA myocardial
model. For all the patients VOI positions were checked to be
similar when processing data with both software packages to
ensure quality of the comparison.
Statistical Analysis
Values are presented as mean ± SD. Continuous mean
values were compared with a Student’s t test. Relations
between PMOD and FlowQuant results were assessed using
Pearson’s correlation (indicating precision), q, Bland-Altman
limit-of-agreement (LOA), and Lin’s concordance correlation
coefficient, qc, a measure of both precision and bias.
25,26 In
fact, Lin’s concordance correlation is the most appropriate test
to measure equivalence of two measurement methods, and
ranges from ?1 (perfect agreement) to 0 (no agreement). In
Lin’s formalism, the precision (Pearson’s correlation q)
illustrates the agreement of the individual measurements from
the best-fit line and the trueness (defined by the bias correction
factor Cb = qc/q) indicates the agreement of the mean test
results from the 45 line-of-identity through the origin (see
Figure 1). The analysis of concordance avoids drawbacks of
some other conventional comparison methods such as the
Pearson’s q used alone (which fails to detect a departure from
the 45 line through the origin), the paired t-test (which could
reject a reproducible method due to small residual error among
means), the least-square approach (slope = 1, intercept = 0,
which would fail to detect departure from the best-fit line if
data are highly scattered), and the coefficient of variation or
the intra-class correlation coefficient (which do not distinguish
bias from imprecision).26 The values of q and qc can be
characterized using the Landis and Koch scale (0.2-0.4: fair;
0.4-0.6: moderate; 0.6-0.8: substantial; 0.8-1.0 almost per-
fect).29 The reduced major axis linear regression (line going
through the intersection of the means with a slope given by the
sign of the Pearson’s correlation and the ratio of the respective
standard deviations) and the locally weighted regression curves
were used in the graphical representations. A P value\ .05
was considered statistically significant. All tests were per-
formed using Stata 10.1 statistical analysis software (Stata
Corporation, College Station, TX, USA).
RESULTS
Process Quality Criteria
All 102 studies were successfully processed with
both FlowQuant and PMOD programs. The reorientation
phase was completed automatically in all cases. For the
myocardial segmentation phase, while FlowQuant ran
automatically for 94% of the stress ? rest studies (3
failures in 102 studies), PMOD failed more frequently
(in about 30% of the cases) requiring manual definition
of the myocardial VOI. For three patients, the automatic
left ventricle VOI delineation did not define blood pool
regions at the same position at stress. These three
patients were excluded from the statistical analysis and
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images were reviewed to obtain similar VOI position
with the two software packages. These three cases are
discussed separately below. Both programs proceeded
successfully through automatic myocardial VOI sam-
pling and kinetic modeling.
LV Quantitative Results
MBF at rest and stress, as well as MFR for the global
LV (n = 48) and for the 17 segments (n = 816) are
displayed in Figure 2; mean ± SD are given in Table 2.
At rest, there was a small (-7%), but statistically
significant mean difference between mean global LV
MBF using PMOD vs FlowQuant (-0.07 ± 0.11 mL/
min/g, P = .0001). Pearson’s correlation (q = 0.95) and
Lin’s concordance (qc = 0.93) were similar, also indi-
cating that no systematic bias was present (Cb = 0.98)
between software packages. At stress, there was also a
small but not clinically significant (5%) mean difference
(0.11 ± 0.34 mL/min/g, P = .036) in global LV MBF
with PMOD vs FlowQuant, leading to a small (12%)
difference in MFR (0.28 ± 0.45, P = .0001). Corre-
sponding Pearson’s correlation and Lin’s concordance
were also similar to each other (q = 0.93, qc = 0.91),
indicating no systematic bias for MBF (Cb = 0.98) and
MFR (q = 0.83, qc = 0.76, Cb = 0.92). The limits of
Figure 2. Comparison of MBF values according to software package. Comparison of global left
ventricular MBF values for (A) rest and (B) stress flows. Comparison at the 17-segment level with
MBF values for (C) rest and (D) stress flows. The identity line (dashed, y = x) and the locally
weighted regression curve (solid) are presented.
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agreement of the Bland-Altman plot of global LV stress
MBF were also fairly narrow (30%) as illustrated in
Figure 3.
At the 17-segment level, there was also good
agreement in MBF results using PMOD vs FlowQuant.
Small, but statistically significant mean differences were
found at rest (-0.10 ± 0.26 mL/min/g, P\ .001) and
for MFR (0.27 ± 0.89, P\ .0001), but not at stress
(0.02 ± 0.57 mL/min/g, P = .39) (Table 2). Pearson’s
correlation and Lin’s concordance were still good for
rest (q = 0.81, qc = 0.79, Cb = 0.97) and stress (q =
0.84, qc = 0.83, Cb = 0.98) and for MFR (q = 0.73,
qc = 0.69, Cb = 0.95) (Figure 4).
As there was no spillover correction for the right
ventricle blood in FlowQuant compared to PMOD, we
wanted to compare septal segments (2, 3, 8, 9, and 14,
with right ventricle spillover correction in PMOD) to
non-septal segments (1, 4-7, 10-13, and 15-17). How-
ever, there was no difference in Pearson’s correlation
and Lin’s concordance (septal segments: q = 0.91, qc =
0.89, Cb = 0.98 vs non-septal segments: q = 0.90,
qc = 0.90, Cb = 0.99, P[ .05).
To assess whether MBF results were influenced by
the presence of regional perfusion heterogeneity, as often
seen with ischemia or infarction, two groups of patients
were determined by consensus of two experienced physi-
cians according to the presence (n = 20) or the absence
(n = 28) of perfusion defect on the rest/stress uptake
images. There was no difference in global rest LV MBF
results between subgroups using either software
(P[ .27), but there was a statistically significant differ-
ence between programs (P\ .01) for both subgroups
(Table 3). There was no difference between PMOD and
FlowQuant estimated global stress MBF in the subgroup
with perfusion heterogeneity (P = .16) nor in the sub-
group without (P = .13) perfusion heterogeneity
(Table 3). Global stress LV MBF was significantly
different between patients with and without perfusion
heterogeneity using either PMOD (P = .036) or Flow-
Quant (P = .009). MFR was significantly lower for
patients with perfusion heterogeneity than those with
perfusion homogeneity when assessed by FlowQuant
(P = .022) but not by PMOD (P = .2).
When both subgroups were compared based on the
17-segment MBF values, a statistical difference between
stress MBF results was observed with both programs
(PMOD: P\ .0001; FlowQuant: P\ .0001). There was
also a significant difference between subgroups at rest
(PMOD: P = .0002; FlowQuant: P = .0005). In both
subgroups, stress MBF was not statistically different
between PMOD and FlowQuant (P[ .45), but MFR was
significantly higher with PMOD than FlowQuant
(P\ .0001). MFR was significantly higher in patients
without perfusion defect when assessed by FlowQuant
(P\ .0001) or PMOD (P = .0009). Pearson’s correla-
tion and Lin’s concordance were very good for global LV
MBF and 17-segment pooled MBF with perfusion
heterogeneity (q = 0.95, qc = 0.94, Cb = 0.99 and
q = 0.89, qc = 0.88, Cb = 0.99) or without (q = 0.97,
qc = 0.96, Cb = 0.99 and q = 0.91, qc = 0.90, Cb =
0.99).
Finally, when pooling rest and stress global LV
MBF (n = 96) or 17-segments values (n = 1632),
PMOD showed slightly higher values than FlowQuant
at the higher range of myocardial blood flows, as
assessed by Bland-Altman and locally weighted regres-
sion analysis. The mean difference between software
packages was therefore better for global LV MBF\
2.0 mL/min/g than for global LV MBF C 2.0 mL/min/g
(-6% ± 15% vs 7% ± 13%, P = .0001, n = 96). Com-
paring all the segments, there was a relative overes-
timation by PMOD software for the highest MBF C 2.0
(mean difference 0.22 ± 0.57 mL/min/g, P\ .0001,
n = 475), which may lead to an overestimation of
MFR (difference 0.5 ± 1.0, P\ .0001). The mean
difference between software packages was therefore
Table 2. Global LV MBF, 17-segment MBF, and MFR results for both PMOD and FlowQuant software
packages
Variable n PMOD FlowQuant P
Rest global LV MBF (mL/min/g) 48 0.94 ± 0.35 1.01 ± 0.35 0.0001
Stress global LV MBF (mL/min/g) 48 2.30 ± 0.89 2.20 ± 0.76 0.04
Stress ? Rest Global LV MBF (mL/min/g) 96 1.60 ± 0.84 1.62 ± 0.96 0.5
Global LV MFR 48 2.52 ± 0.81 2.24 ± 0.67 0.0001
Rest 17-segment MBF (mL/min/g) 816 0.92 ± 0.42 1.01 ± 0.42 \0.0001
Stress 17-segment MBF (mL/min/g) 816 2.25 ± 1.07 2.23 ± 0.87 0.4
Stress ? Rest 17-segment MBF (mL/min/g) 1632 1.58 ± 1.53 1.62 ± 0.92 0.0004
17-segment MFR 816 2.63 ± 1.29 2.36 ± 1.03 \0.0001
Values displayed as mean ± SD. LV, Left ventricle; MBF, myocardial blood flow; MFR, myocardial flow reserve
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better for MBF\ 2.0 than for MBF C 2.0 (-14% ±
31% vs 8% ± 20%, P\ .0001, n = 1632). In spite of
this finding, correlation and concordance between both
software packages were very good for global LV MBF
as well as for 17-segment values (q = 0.97, qc = 0.96,
Cb = 0.99 and q = 0.9, qc = 0.9, Cb = 0.99, respec-
tively) (Table 4).
When analyzing the proportion of normal vs
abnormal studies, the results were very close, either at
the patient level or at the segment level (Table 5). There
was a small, but statistically significant difference at the
segmental level that is not likely to be clinically
relevant, as demonstrated by no significant difference
at the whole left-ventricle level, or when using both
stress MBF and MFR to define normal values (stress
MBF C 2.0 mL/min/g or MFR C 2.0).
Analysis of the Three Excluded Patients
Interestingly, the automatic left ventricle VOI
delineation was discordant between software packages
in 3 subjects at stress. This resulted in a relative
overestimation of MBF with PMOD compared to
FlowQuant (difference 1.5 ± 0.4 mL/min/g, P = .004).
For these 3 patients, summed uptake images had the
same orientation on both software packages. While left
blood spillover values with PMOD remained in the
normal range and were not different from FlowQuant
values, the K1 and k2 values were higher and DV (K1/k2)
lower with PMOD as compared to FlowQuant. Since the
values of the ‘‘a’’ and ‘‘b’’ parameters of the extraction
function were the same for both software packages, as
reported by Lortie et al.14 we attributed the discrepancy
to differences in input functions resulting in overesti-
mation of the K1 parameter value. Examination of
dynamic sequences with PMOD revealed that for two of
the three patients, the LV VOI used for the input
function was sub-optimally located. In the first patient,
the maximal blood input activity was shifted basally.
Figure 3. Bland-Altman plot of difference vs average global
LV stress MBF (n = 48) between software packages. Legend:
dashed line = mean difference = 0.11 mL/min/g [5%, P =
.036]; shaded area = ±95% limits of agreements [-0.56-
0.77 mL/min/g].
Figure 4. Comparison of MBF values according to software
package: (A) comparison of global LV MBF values; (B)
comparison of regional 17-segment MBF values. The identity
line (short dash, y = x) and the locally weighted regression
curve (solid) are presented.
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Table 4. PMOD vs FlowQuant concordance correlation coefficients
n
Pearson’s
q [95% CI] qc [95% CI] Cb
Reduced major axis
PMOD 5 f (FQ)
Global left ventricle
Rest MBF (mL/min/g) 48 0.95 [0.91–0.97] 0.93 [0.89–0.97] 0.98 y = 0.99x - 0.06
Stress MBF (mL/min/g) 48 0.93 [0.88–0.96] 0.91 [0.86–0.95] 0.98 y = 1.18x - 0.29
Stress ? Rest MBF (mL/min/g) 96 0.97 [0.95–0.98] 0.96 [0.94–0.97] 0.99 y = 1.15x - 0.22
MFR (unitless ratio) 48 0.83 [0.72–0.90] 0.76 [0.66–0.87] 0.92 y = 1.22x - 0.20
17-Segment level
Rest MBF (mL/min/g) 816 0.81 [0.78–0.83] 0.79 [0.76–0.81] 0.97 y = 1.00x - 0.10
Stress MBF (mL/min/g) 816 0.84 [0.82–0.86] 0.83 [0.81–0.85] 0.98 y = 1.23x - 0.49
Stress ? Rest MBF (mL/min/g) 1632 0.90 [0.90–0.91] 0.90 [0.89–0.90] 0.99 y = 1.15x - 0.28
MFR (unitless ratio) 816 0.73 [0.70–0.76] 0.69 [0.66–0.73] 0.95 y = 1.25x - 0.33
q, Pearson’s correlation (precision); qc, Lin’s concordance correlation; Cb, qc/q = bias correction factor (trueness); LV, left ventricle;
MBF, myocardial blood flow; MFR, myocardial flow reserve
Table 5. PMOD vs FlowQuant classification of normal vs abnormal stress myocardial blood flow (MBF)
and myocardial flow reserve (MFR)
Normal MBF or MFR values n PMOD FlowQuant Difference P
Whole left-ventricle
Stress MBF C 2.0 mL/min/g 48 30 (63%) 31 (65%) 1 (2.1%) 0.84
MFR C 2 (unitless ratio) 48 34 (71%) 30 (63%) 4 (8.3%) 0.40
17-Segment level
Stress MBF C 2.0 mL/min/g 816 456 (56%) 488 (60%) 32 (3.9%) 0.10
MFR C 2 (unitless ratio) 816 543 (67%) 485 (59%) 58 (7.1%) 0.0008
Whole left-ventricle
Stress MBF C 2.0 mL/min/g or
MFR C 2 (unitless ratio)
48 40 (78%) 41 (80%) 1 (2.0%) 0.81
17-Segment level
Stress MBF C 2.0 mL/min/g or
MFR C 2 (unitless ratio)
816 617 (76%) 613 (75%) 2 (0.2%) 0.64
Table 3. Software comparison in patients with or without regional perfusion heterogeneities
Perfusion
PMOD FlowQuant
Heterogeneous
n 5 20
Homogenous
n 5 28
Heterogeneous
n 5 20
Homogenous
n 5 28
Rest global LV MBF (mL/min/g) 0.87 ± 0.31 0.98 ± 0.37 0.94 ± 0.32* 1.08 ± 0.37*
Stress global LV MBF (mL/min/g) 1.98 ± 0.92 2.53 ± 0.82 1.87 ± 0.78 2.43 ± 0.65
Global LV MFR (unitless ratio) 2.35 ± 1.01 2.65 ± 0.63 1.98 ± 0.66 2.43 ± 0.61*,§,||
*PMOD vs FlowQuant in heterogeneous (P = .002) and homogeneous perfusion (P = .01); Heterogeneous vs homogeneous
perfusion with PMOD (P = .04) and FlowQuant (P = .009); PMOD vs FlowQuant in heterogeneous perfusion (P = .003); §PMOD
vs FlowQuant in homogeneous perfusion (P = 0.01); ||Heterogeneous vs homogeneous perfusion with FlowQuant (P = 0.02).
LV, Left ventricle; MBF, myocardial blood flow; MFR, myocardial flow reserve
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With PMOD, the automatic VOI was placed too deep in
the LV cavity leading to underestimation of the input
function (Figures 5A, 5C). In contrast, FlowQuant
correctly placed and used the median TAC of three
atrial, basal, and cavity TACs (Figure 5B). Correction of
the PMOD VOI position led to increased blood input
function and decreased MBF differences among soft-
ware packages (Figure 5D). In the third patient, while
not detectable on the summed uptake image, examina-
tion of the dynamic sequence revealed patient motion
during tracer infusion. PMOD’s blood VOI was there-
fore too deep in the cavity, whereas FlowQuant’s VOI
was more posterior, resulting in a more appropriate input
function. As for the first patient, manual correction of
PMOD’s blood VOI diminished the MBF difference
between software methods.
DISCUSSION
To our knowledge this is the first study comparing
two software packages commonly used for MBF quan-
tification with 82Rb PET with detailed statistical analysis
of concordance. In comparing these two software
packages, we found several differences, whereas the
LV reorientation process was successfully run with both
PMOD and FlowQuant, there was a large difference in
automatic VOI determination. FlowQuant processing
failed in only 6% of the scans, whereas PMOD VOI
determination had to be manually determined for
approximately one-third of the studies. Once VOIs were
well placed, the rest of the processing ran automatically
for both software packages.
Although myocardial uptake images were similar,
there were significant differences regarding quantitative
Figure 5. (A) Comparison of left ventricular blood pool input function (activity in voxel of interest
[VOI] vs time) for a patient with differences in size and placement of the VOI leading to differences
in stress LV MBF between (B) FQ and (C) PMOD software packages. When a similar VOI was
used in PMOD as in FQ, differences were much smaller (D).
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results. The overall rest MBF, stress MBF, and MFR
assessed from 82Rb-PET data were similar to the CAD
population of a previous study using the same kinetic
model,14 with higher rest MBF and, lower stress MBF
and MFR as compared to previous publications in
healthy volunteer populations.14,16 Stress global LV
MBF was significantly higher using PMOD, leading to
slightly higher values of MFR as compared to Flow-
Quant, but of little clinical relevance, however. We
found similar results using global LV MBF or 17-
segment MBF, suggesting that differences in MFR could
neither be due to differences in reorientation, as
qualitatively assessed when looking at uptake image
reorientation, nor to myocardial sampling or to two-
compartment model characteristics.11 Moreover, the
absence of significant difference between PMOD and
FlowQuant for septal and non-septal segments empha-
sizes that it cannot be due to differences in RV blood
spillover correction in the septum. Thus, our study
shows that changes due to RV blood spillover correction
methods are not significant, which is contrary to what
has been hypothesized as a source of possible difference
among software packages recently by Tahari et al.23
For three patients with difference in automatic left
ventricle VOI delineation, we found that two of the three
higher MBF values with PMOD were partly due to
lower input functions leading to overestimation of K1
and stress MBF. This highlights the importance of
careful blood pool sampling for the arterial input
function, as recently investigated by Vasquez et al30
and Armstrong et al,31 with increased MBF value in case
of decreased arterial input function. The higher MBF
values by PMOD as compared to FlowQuant occurred at
the highest range of MBF, where small differences in K1
are amplified by higher extraction correction factors.
Regarding the perfusion status, there was a small
but statistically significant difference between homoge-
neous vs heterogeneous polar maps for stress global LV
MBF with FlowQuant (P = .009) or with PMOD
(P = .036). MFR was however significantly lower for
patients with heterogeneous perfusion than for patients
with homogeneous perfusion using FlowQuant
(P = .022) but not using PMOD (P = .2). Although
there were higher values for stress MBF and MFR with
PMOD as compared to FlowQuant, the concordance was
very good as reflected by Pearson correlation val-
ues[ 0.83 for global estimates. Moreover, differences
mainly concerned stress MBF C 2.0 mL/min/g, which
might not result in different clinical management in
daily practice. Although we can be confident that both
packages may be used interchangeably in the clinical
setting from the present study, it cannot be inferred from
our data that this would hold true when performing
multi-center trials or for studies designed to determine
specific MBF or MFR thresholds based on normal
populations.22,32
Although similar studies exist on multiple software
package comparisons for MBF quantification,20-24 in-
cluding PMOD and FlowQuant,22 the present study
presents a more detailed comparison using Lin’s con-
cordance analysis, which allows to grasp the nature of
the observed difference and shows no systematic bias
(agreement cannot be improved by a linear transforma-
tion of the results) and that any disagreement was mostly
due to measurement precision.
NEW KNOWLEDGE GAINED
The present work comparing two software packages
using contemporary statistical methods (analysis of
concordance) was able to discriminate between mea-
surement precision and bias to understand the nature of
the observed differences. The lack of systematic bias
between methods suggests that they may be used
interchangeably and shows that observed variations
were mostly due to measurement precision. Although
group comparison of multiple software programs exist,
one-to-one concordance analysis allows better under-
standing of the disagreements and is needed before data
from two software packages can be pooled in multi-
center studies or before thresholds derived from one
software package can be applied to another.
CONCLUSION
While faster and more often successful automatic
processing was achieved with FlowQuant, both software
packages led to very similar results. Concordance in
measured values was excellent for quantification of rest
MBF, stress MBF, and MFR without systematic differ-
ences, despite relatively higher values with PMOD as
compared to FlowQuant, in particular at the highest MBF
leading to mild overestimation of MFR. There were no
difference between FlowQuant and PMOD regarding the
ability to distinguish between normal vs abnormal flow at
the whole LV level. A small difference was seen at the
segmental level in the number of normal segments, but it
is not expected to lead to difference in clinical manage-
ment. We conclude that both software packages can be
used interchangeably for analyzing clinical 82Rb dynamic
cardiac PET studies in daily practice.
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